Professional
Added to YB: 2026-09-28
Pitch date: 2026-09-23
LFMD [neutral]
LifeMD, Inc.
-2.3%
current return
Author Info
Pernas Research is a former CIO of a $3.5B fund that now share actionable stock research. Sign up for the newsletter.
Company Info
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States.
Market Cap
$147.0M
Pitch Price
$3.04
Price Target
N/A
Dividend
N/A
EV/EBITDA
-7.32
P/E
-5.51
EV/Sales
0.67
Sector
Health Care Technology
Category
N/A
Pass on LifeMD (LFMD)
LFMD (pass): LifeMD is trying to evolve from an ad-driven telehealth clinic into a vertically integrated chronic-care platform, but its customer-acquisition model remains challenged by larger competitors such as Hims that can outspend it. Last quarter, LifeMD spent roughly $30 million on marketing to generate about $50 million of revenue even as revenue declined year over year; insurer and AT&T channels may help temporarily, but competitors can pursue similar partnerships.
Read full article (1 min)